GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
123.11
+6.70 (5.76%)
At close: Aug 13, 2025, 4:00 PM
119.22
-3.89 (-3.16%)
Pre-market: Aug 14, 2025, 9:06 AM EDT
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$362,321
Profits / Employee
$1,406
Market Cap
3.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,000 | 0 | - |
Dec 31, 2023 | 1,000 | -100 | -9.09% |
Dec 31, 2022 | 1,100 | -100 | -8.33% |
Dec 31, 2021 | 1,200 | 328 | 37.61% |
Dec 31, 2020 | 872 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
WGS News
- 7 days ago - Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewsWire
- 8 days ago - GeneDx to Participate in Upcoming Investor Conferences - Business Wire
- 13 days ago - GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth - Seeking Alpha
- 14 days ago - WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group - PRNewsWire
- 14 days ago - GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 15 days ago - GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire
- 16 days ago - WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm - PRNewsWire